US Patent Number

9,566,341

Publication Date

2-14-2017

Abstract

The presently-disclosed subject matter includes compounds including a cyclooxygenase enzyme inhibitor moiety and a moiety derived from a drug of interest. In some embodiments, the drug of interest is an opioid. In some embodiments, the compound includes a diclofenac moiety and a naltrexone or naltrexol moiety. The compounds allow for enhanced delivery rates across skin.

Assignees

University of Kentucky Research Foundation, Lexington, KY (US)

Application Number

13/458,366

Filing Date

2-27-2012

Share

COinS